C73 Billable / specific Malignant neoplasm of thyroid gland
ICD-10-CM C73 identifies “Malignant neoplasm of thyroid gland” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapter 2: Neoplasms
Code-level instructions
Use additional code1
code to identify any functional activity
Inherited instructions
Chapters 2 · Neoplasms (C00-D49)
Note8
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
Official index references
Official index references (32)
Adenocarcinoma (9)
- Adenocarcinoma › follicular › with papillaryDisease index
- Adenocarcinoma › follicular › moderately differentiatedDisease index
- Adenocarcinoma › follicular › trabecularDisease index
- Adenocarcinoma › follicular › unspecified siteDisease index
- Adenocarcinoma › follicular › well differentiatedDisease index
- Adenocarcinoma › Hurthle cellDisease index
- Adenocarcinoma › nonencapsulated sclerosingDisease index
- Adenocarcinoma › papillary › with follicularDisease index
- Adenocarcinoma › papillary › follicular variantDisease index
Carcinoma(malignant) (14)
- Carcinoma(malignant) › C cell › unspecified siteDisease index
- Carcinoma(malignant) › follicular › with papillary(mixed)Disease index
- Carcinoma(malignant) › follicular › moderately differentiatedDisease index
- Carcinoma(malignant) › follicular › pure follicleDisease index
- Carcinoma(malignant) › follicular › trabecularDisease index
- Carcinoma(malignant) › follicular › unspecified siteDisease index
- Carcinoma(malignant) › follicular › well differentiatedDisease index
- Carcinoma(malignant) › Hurthle cellDisease index
- Carcinoma(malignant) › medullary › with › amyloid stroma › unspecified siteDisease index
- Carcinoma(malignant) › nonencapsulated sclerosingDisease index
- Carcinoma(malignant) › papillary › with follicular(mixed)Disease index
- Carcinoma(malignant) › papillary › follicular variantDisease index
- Carcinoma(malignant) › parafollicular cell › unspecified siteDisease index
- Carcinoma(malignant) › solid › with amyloid stroma › unspecified siteDisease index
Goiter(plunging) (substernal) (2)
- Goiter(plunging) (substernal) › cancerousDisease index
- Goiter(plunging) (substernal) › malignantDisease index
Hurthle cell (2)
- Hurthle cell › adenocarcinomaDisease index
- Hurthle cell › carcinomaDisease index
Neoplasm, neoplastic (2)
Tumor (2)
- Tumor › Hurthle cell(benign) › malignantDisease index
- Tumor › nonencapsulated sclerosingDisease index
Wuchernde Struma Langhans (1)
- Wuchernde Struma LanghansDisease index
References from other codes (2)
Excludes 1 · malignant neoplasm of thyroid gland (C73)
Inclusion terms · Conditions classifiable to C73-C75
History
Code history
No recorded change since first observation
ChangedUnchanged
FY2016
Effective from
- First observed
Malignant neoplasm of thyroid gland
Billable diagnosis code
CDC/NCHS · FY2016All editions (19)
| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | No tabular change |
| FY2018 | 2017-10-01 | No tabular change |
| FY2019 | 2018-10-01 | No tabular change |
| FY2020 | 2019-10-01 | No tabular change |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | No tabular change |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | No tabular change |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
Historical ICD-9 mappings · 2018
Historical mapping only; not an automatic code substitution.
- 193
This entry is a complete code in the selected edition. Reference checks do not establish clinical appropriateness or guarantee reimbursement.